Back to search

Article

Pooled evidence precision of clinical trials on hydroxychloroquine for Covid-19 treatment was stabilized eight months after the outbreak

2024-01-22

Abstract excerpt

<h4>ABSTRACT</h4> <h4>OBJECTIVE</h4> At the beginning of 2020, hydroxychloroquine showed promising in vitro activity for Covid-19 and several studies were oriented to assess its safety and efficacy. However, after a few months, hydroxychloroquine has proved ineffective. The randomized controlled trials (RCTs) developed quickly and in different settings represent the scientific community’s capacity to assess drug r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
333b083b-f54a-5491-837a-618727904f75
DOI
10.1101/2024.01.21.24301572
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pooled evidence precision of clinical trials on hydroxychloroquine for Covid-19 treatment was stabilized eight months after the outbreakDOI 10.1101/2024.01.21.24301572
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trialsSemantic proximity
Hydroxychloroquine and mortality risk of patients with COVID-19: a systematic review and meta-analysis of human comparative studiesSemantic proximity
Low dose hydroxychloroquine is associated with lower mortality in COVID-19: a meta-analysis of 26 studies and 44,521 patientsSemantic proximity
Efficacy and safety outcomes in randomized controlled trials investigating hydroxychloroquine for COVID-19Semantic proximity
Hydroxychloroquine/Chloroquine in COVID-19 With Focus on Hospitalized Patients – A Systematic ReviewSemantic proximity
Low Dose Hydroxychloroquine is Associated with Lower Mortality in COVID-19: A Meta-Analysis of 27 Studies and 44,684 PatientsSemantic proximity
HYDROXYCHLOROQUINE FOR THE TREATMENT OF SEVERE RESPIRATORY INFECTION BY COVID-19: A RANDOMIZED CONTROLLED TRIALSemantic proximity
Disentangling the association of hydroxychloroquine treatment with mortality in Covid-19 hospitalized patients through Hierarchical ClusteringSemantic proximity
Hydroxychloroquine for prevention of COVID-19 mortality: a population-based cohort studySemantic proximity
Hydroxychloroquine with or Without Azithromycin for Treatment of Early SARS-CoV-2 Infection Among High-Risk Outpatient Adults: A Randomized Clinical TrialSemantic proximity
Hydroxychloroquine Alone or in Combination with Cobicistat-Boosted Darunavir for Treatment of Mild COVID-19: A Cluster-Randomized Clinical TrialSemantic proximity
Preventing disease after exposure to COVID-19 using hydroxychloroquine: A summary of a protocol for exploratory re-analysis of age and time-nuanced effectsSemantic proximity
Select a neighboring publication to make it the new centre.